Dr Reddys Laboratories Debt-to-Equity Ratio Growth & History (RDY)

Dr Reddys Laboratories's debt-to-equity ratio was 0.14 for fiscal 2025.

View full Dr Reddys Laboratories company overview

Dr Reddys Laboratories annual debt-to-equity ratio history

Dr Reddys Laboratories annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20252025-03-310.140.07+105.83%
20242024-03-310.070.03+77.20%
20232023-03-310.04−0.13−78.12%
20222022-03-310.170.00+1.49%
20212021-03-310.170.06+48.65%
20202020-03-310.11−0.13−53.01%
20192019-03-310.24−0.16−39.13%
20182018-03-310.40

Dr Reddys Laboratories debt-to-equity ratio trends

Over the last five fiscal years, Dr Reddys Laboratories's debt-to-equity ratio increased from 0.11 to 0.14, a change of 0.02. The latest reported quarter, Q4 2025, shows 0.14.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Dr Reddys Laboratories source filings ↗

Community posts

It’s quiet here.

No posts about RDY yet. Start the conversation.

Write the first post